Life Sciences Tools & Services Companies By Pe Ratio

Price To Earning
Price To EarningEfficiencyMarket RiskExp Return
1MLAB Mesa Laboratories
433.94
(0.02)
 2.87 
(0.05)
2CSBR Champions Oncology
220.0
 0.04 
 5.48 
 0.24 
3PACB Pacific Biosciences of
197.88
(0.09)
 6.15 
(0.56)
4RGEN Repligen
154.58
(0.02)
 3.17 
(0.07)
5IQV IQVIA Holdings
103.68
(0.10)
 1.61 
(0.16)
6TECH Bio Techne Corp
74.38
(0.14)
 2.18 
(0.31)
7AVTR Avantor
72.98
(0.14)
 2.75 
(0.40)
8BRKR Bruker
67.1
(0.19)
 2.59 
(0.50)
9SHC Sotera Health Co
61.32
(0.08)
 2.20 
(0.18)
10ILMN Illumina
49.12
(0.28)
 2.73 
(0.75)
11MEDP Medpace Holdings
49.07
(0.03)
 1.98 
(0.06)
12WAT Waters
40.43
 0.01 
 1.82 
 0.01 
13AZTA Azenta Inc
38.92
(0.19)
 2.77 
(0.52)
14MTD Mettler Toledo International
38.4
(0.01)
 1.59 
(0.02)
15A Agilent Technologies
37.55
(0.13)
 1.64 
(0.22)
16ICLR ICON PLC
33.93
(0.11)
 2.07 
(0.24)
17CRL Charles River Laboratories
33.74
(0.10)
 2.35 
(0.24)
18TMO Thermo Fisher Scientific
30.99
(0.01)
 1.54 
(0.01)
19NOTV Inotiv Inc
30.91
(0.10)
 6.98 
(0.72)
20QGEN Qiagen NV
24.32
(0.12)
 1.51 
(0.18)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit. Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.